Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Backs EPCIS, Refines Advice As November 2023 DSCSA Deadline Approaches
Jul 06 2022
•
By
Bowman Cox
Further anti-counterfeiting refinements from the fda • Source: Shutterstock
More from Manufacturing
More from Compliance